OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 142 citing articles:

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Yen‐Ju Lin, Martina Anzaghe, Stefan Schülke
Cells (2020) Vol. 9, Iss. 4, pp. 880-880
Open Access | Times Cited: 687

The biology and functional importance of MAIT cells
Dale I. Godfrey, Hui‐Fern Koay, James McCluskey, et al.
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1110-1128
Closed Access | Times Cited: 458

Rheumatic manifestations of chikungunya: emerging concepts and interventions
Andreas Suhrbier
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 10, pp. 597-611
Open Access | Times Cited: 160

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Shahin Shams, Joseph Martinez, John R.D. Dawson, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 109

Systemic effects of IL-17 in inflammatory arthritis
Audrey Beringer, Pierre Miossec
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 8, pp. 491-501
Closed Access | Times Cited: 104

The Immunomodulatory and Anti-Inflammatory Effect of Curcumin on Immune Cell Populations, Cytokines, and In Vivo Models of Rheumatoid Arthritis
Sebastian Makuch, Kamil Więcek, Marta Woźniak
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 309-309
Open Access | Times Cited: 59

Artificial intelligence-driven drug development against autoimmune diseases
Philippe Moingeon
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 411-424
Open Access | Times Cited: 25

IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation
Federica Raucci, Asif Iqbal, Anella Saviano, et al.
Pharmacological Research (2019) Vol. 147, pp. 104351-104351
Open Access | Times Cited: 58

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
Carlos Rafael‐Vidal, Nair Pérez, Irene Altabás, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7100-7100
Open Access | Times Cited: 58

Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis–like disease and inflammation
Bahram Razani, Michael I. Whang, Francis S. Kim, et al.
Nature Immunology (2020) Vol. 21, Iss. 4, pp. 422-433
Open Access | Times Cited: 54

Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting
Pierre Miossec
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 4, pp. 860-865
Open Access | Times Cited: 41

Precision medicine: the precision gap in rheumatic disease
Chung Mun Alice Lin, Faye A. H. Cooles, John D. Isaacs
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 12, pp. 725-733
Closed Access | Times Cited: 30

A Review of the Safety of Interleukin-17A Inhibitor Secukinumab
Vishnu Eshwar, Ashwin Kamath, Rajeshwari Shastry, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1365-1365
Open Access | Times Cited: 30

Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)
Payal Ganguly, Tom Macleod, Chi Huey Wong, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1286-1286
Open Access | Times Cited: 22

IL-17 in osteoarthritis: A narrative review
Juan Xiao, Ping Zhang, Fang-Lan Cai, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 19

Yoga maintains Th17/Treg cell homeostasis and reduces the rate of T cell aging in rheumatoid arthritis: a randomized controlled trial
Surabhi Gautam, Romsha Kumar, Uma Kumar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17

The Lung in Rheumatoid Arthritis—Friend or Enemy?
Maria-Luciana Anton, Anca Cardoneanu, Alexandra Burlui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6460-6460
Open Access | Times Cited: 7

Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation
Marie Robert, Pierre Miossec
Autoimmunity Reviews (2024) Vol. 23, Iss. 4, pp. 103529-103529
Closed Access | Times Cited: 6

Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
Anna Kovalchuk, Bo Wang, Dongping Li, et al.
Aging (2021) Vol. 13, Iss. 2, pp. 1571-1590
Open Access | Times Cited: 36

8-Shogaol inhibits rheumatoid arthritis through targeting TAK1
Seongin Jo, Snigdha Samarpita, Ji Su Lee, et al.
Pharmacological Research (2022) Vol. 178, pp. 106176-106176
Closed Access | Times Cited: 27

The Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Marie Robert, Pierre Miossec, A. Hot
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
A Ram Lee, Jin Seok Woo, Seon-Yeong Lee, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15

Linalool: Monoterpene alcohol effectiveness in chronic synovitis through lowering Interleukin-17, spleen and thymus indices
Shoaib Nawaz, Hafiz Muhammad Irfan, Alamgeer Umme Habiba Hasan, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110517-110517
Closed Access | Times Cited: 14

Association Between IL-17 and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Ru Ma, Hongling Su, Keping Jiao, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 1681-1690
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top